ID   UB2E1_HUMAN             Reviewed;         193 AA.
AC   P51965; B2RBX4; C9J8K2; K4DI90;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   10-MAY-2017, entry version 175.
DE   RecName: Full=Ubiquitin-conjugating enzyme E2 E1;
DE            EC=2.3.2.23 {ECO:0000269|PubMed:20061386};
DE   AltName: Full=(E3-independent) E2 ubiquitin-conjugating enzyme E1;
DE            EC=2.3.2.24 {ECO:0000269|PubMed:17588522};
DE   AltName: Full=E2 ubiquitin-conjugating enzyme E1;
DE   AltName: Full=UbcH6;
DE   AltName: Full=Ubiquitin carrier protein E1;
DE   AltName: Full=Ubiquitin-protein ligase E1;
GN   Name=UBE2E1; Synonyms=UBCH6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8576257; DOI=10.1074/jbc.271.5.2795;
RA   Nuber U., Schwarz S., Kaiser P., Schneider R., Scheffner M.;
RT   "Cloning of human ubiquitin-conjugating enzymes UbcH6 and UbcH7 (E2-
RT   F1) and characterization of their interaction with E6-AP and RSP5.";
RL   J. Biol. Chem. 271:2795-2800(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Cervix carcinoma, Colon, and Hypothalamus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, AND ISGYLATION AT LYS-136.
RX   PubMed=16428300; DOI=10.1093/jb/mvi172;
RA   Takeuchi T., Iwahara S., Saeki Y., Sasajima H., Yokosawa H.;
RT   "Link between the ubiquitin conjugation system and the ISG15
RT   conjugation system: ISG15 conjugation to the UbcH6 ubiquitin E2
RT   enzyme.";
RL   J. Biochem. 138:711-719(2005).
RN   [7]
RP   CATALYTIC ACTIVITY AS E3-INDEPENDENT E2 UBIQUITIN-CONJUGATING ENZYME.
RX   PubMed=17588522; DOI=10.1016/j.molcel.2007.05.014;
RA   Hoeller D., Hecker C.M., Wagner S., Rogov V., Doetsch V., Dikic I.;
RT   "E3-independent monoubiquitination of ubiquitin-binding proteins.";
RL   Mol. Cell 26:891-898(2007).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=18845142; DOI=10.1016/j.yexcr.2008.09.011;
RA   Espinosa A., Oke V., Elfving A., Nyberg F., Covacu R.,
RA   Wahren-Herlenius M.;
RT   "The autoantigen Ro52 is an E3 ligase resident in the cytoplasm but
RT   enters the nucleus upon cellular exposure to nitric oxide.";
RL   Exp. Cell Res. 314:3605-3613(2008).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=20061386; DOI=10.1074/jbc.M109.089003;
RA   David Y., Ziv T., Admon A., Navon A.;
RT   "The E2 ubiquitin-conjugating enzymes direct polyubiquitination to
RT   preferred lysines.";
RL   J. Biol. Chem. 285:8595-8604(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
CC   -!- FUNCTION: Accepts ubiquitin from the E1 complex and catalyzes its
CC       covalent attachment to other proteins. Catalyzes the covalent
CC       attachment of ISG15 to other proteins. Mediates the selective
CC       degradation of short-lived and abnormal proteins. In vitro also
CC       catalyzes 'Lys-48'-linked polyubiquitination.
CC       {ECO:0000269|PubMed:16428300, ECO:0000269|PubMed:20061386}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E1 ubiquitin-activating
CC       enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine
CC       = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2
CC       ubiquitin-conjugating enzyme]-L-cysteine. {ECO:0000255|PROSITE-
CC       ProRule:PRU00388, ECO:0000255|PROSITE-ProRule:PRU10133,
CC       ECO:0000269|PubMed:20061386}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E1 ubiquitin-activating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E1 ubiquitin-
CC       activating enzyme]-L-cysteine + N(6)-monoubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000269|PubMed:17588522}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -!- SUBUNIT: Interacts with RNF14.
CC   -!- INTERACTION:
CC       Q99PZ6:ospG (xeno); NbExp=3; IntAct=EBI-348546, EBI-9316527;
CC       Q96FW1:OTUB1; NbExp=3; IntAct=EBI-348546, EBI-1058491;
CC       Q8N7H5:PAF1; NbExp=2; IntAct=EBI-348546, EBI-2607770;
CC       Q9Y3C5:RNF11; NbExp=2; IntAct=EBI-348546, EBI-396669;
CC       Q5VTR2:RNF20; NbExp=2; IntAct=EBI-348546, EBI-2372238;
CC       Q8ND25:ZNRF1; NbExp=3; IntAct=EBI-348546, EBI-2129250;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18845142}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P51965-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P51965-2; Sequence=VSP_045884;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P51965-3; Sequence=VSP_047200;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: ISGylation suppresses ubiquitin E2 enzyme activity.
CC       {ECO:0000269|PubMed:16428300}.
CC   -!- SIMILARITY: Belongs to the ubiquitin-conjugating enzyme family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X92963; CAA63539.1; -; mRNA.
DR   EMBL; AK314854; BAG37371.1; -; mRNA.
DR   EMBL; AC020626; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124914; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471055; EAW64329.1; -; Genomic_DNA.
DR   EMBL; CH471055; EAW64331.1; -; Genomic_DNA.
DR   EMBL; CH471055; EAW64332.1; -; Genomic_DNA.
DR   EMBL; BC009139; AAH09139.1; -; mRNA.
DR   EMBL; BI223271; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BI666638; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS2638.1; -. [P51965-1]
DR   CCDS; CCDS2639.1; -. [P51965-3]
DR   CCDS; CCDS56244.1; -. [P51965-2]
DR   RefSeq; NP_001189405.1; NM_001202476.1. [P51965-2]
DR   RefSeq; NP_003332.1; NM_003341.4. [P51965-1]
DR   RefSeq; NP_872607.1; NM_182666.2. [P51965-3]
DR   UniGene; Hs.164853; -.
DR   PDB; 1XR9; X-ray; 1.79 A; C=83-91.
DR   PDB; 3BZH; X-ray; 1.60 A; A=1-193.
DR   PDB; 4JJQ; X-ray; 1.95 A; B=5-14.
DR   PDBsum; 1XR9; -.
DR   PDBsum; 3BZH; -.
DR   PDBsum; 4JJQ; -.
DR   ProteinModelPortal; P51965; -.
DR   SMR; P51965; -.
DR   BioGrid; 113172; 125.
DR   IntAct; P51965; 67.
DR   MINT; MINT-109083; -.
DR   STRING; 9606.ENSP00000303709; -.
DR   iPTMnet; P51965; -.
DR   PhosphoSitePlus; P51965; -.
DR   BioMuta; UBE2E1; -.
DR   DMDM; 1717857; -.
DR   EPD; P51965; -.
DR   MaxQB; P51965; -.
DR   PaxDb; P51965; -.
DR   PeptideAtlas; P51965; -.
DR   PRIDE; P51965; -.
DR   Ensembl; ENST00000306627; ENSP00000303709; ENSG00000170142. [P51965-1]
DR   Ensembl; ENST00000346855; ENSP00000329113; ENSG00000170142. [P51965-3]
DR   Ensembl; ENST00000424381; ENSP00000411351; ENSG00000170142. [P51965-2]
DR   GeneID; 7324; -.
DR   KEGG; hsa:7324; -.
DR   UCSC; uc003cch.4; human. [P51965-1]
DR   CTD; 7324; -.
DR   DisGeNET; 7324; -.
DR   GeneCards; UBE2E1; -.
DR   HGNC; HGNC:12477; UBE2E1.
DR   HPA; CAB073413; -.
DR   HPA; HPA030445; -.
DR   MIM; 602916; gene.
DR   neXtProt; NX_P51965; -.
DR   OpenTargets; ENSG00000170142; -.
DR   PharmGKB; PA37127; -.
DR   eggNOG; KOG0417; Eukaryota.
DR   eggNOG; COG5078; LUCA.
DR   GeneTree; ENSGT00760000119012; -.
DR   HOGENOM; HOG000233455; -.
DR   HOVERGEN; HBG063308; -.
DR   InParanoid; P51965; -.
DR   KO; K20217; -.
DR   OMA; SPGWGCG; -.
DR   OrthoDB; EOG091G0GF8; -.
DR   PhylomeDB; P51965; -.
DR   TreeFam; TF101117; -.
DR   BRENDA; 2.3.2.B6; 2681.
DR   Reactome; R-HSA-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-HSA-141430; Inactivation of APC/C via direct inhibition of the APC/C complex.
DR   Reactome; R-HSA-174048; APC/C:Cdc20 mediated degradation of Cyclin B.
DR   Reactome; R-HSA-174084; Autodegradation of Cdh1 by Cdh1:APC/C.
DR   Reactome; R-HSA-174154; APC/C:Cdc20 mediated degradation of Securin.
DR   Reactome; R-HSA-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; R-HSA-174184; Cdc20:Phospho-APC/C mediated degradation of Cyclin A.
DR   Reactome; R-HSA-176407; Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase.
DR   Reactome; R-HSA-176408; Regulation of APC/C activators between G1/S and early anaphase.
DR   Reactome; R-HSA-176409; APC/C:Cdc20 mediated degradation of mitotic proteins.
DR   Reactome; R-HSA-176412; Phosphorylation of the APC/C.
DR   Reactome; R-HSA-179409; APC-Cdc20 mediated degradation of Nek2A.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-8866652; Synthesis of active ubiquitin: roles of E1 and E2 enzymes.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; P51965; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; UBE2E1; human.
DR   EvolutionaryTrace; P51965; -.
DR   GeneWiki; UBE2E1; -.
DR   GenomeRNAi; 7324; -.
DR   PRO; PR:P51965; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000170142; -.
DR   CleanEx; HS_UBE2E1; -.
DR   ExpressionAtlas; P51965; baseline and differential.
DR   Genevisible; P51965; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000151; C:ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042296; F:ISG15 transferase activity; IDA:HGNC.
DR   GO; GO:0061631; F:ubiquitin conjugating enzyme activity; IDA:BHF-UCL.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0031145; P:anaphase-promoting complex-dependent catabolic process; TAS:Reactome.
DR   GO; GO:0033523; P:histone H2B ubiquitination; IDA:UniProtKB.
DR   GO; GO:0010390; P:histone monoubiquitination; IDA:UniProtKB.
DR   GO; GO:0032020; P:ISG15-protein conjugation; IDA:HGNC.
DR   GO; GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition; TAS:Reactome.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; TAS:Reactome.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:BHF-UCL.
DR   GO; GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; TAS:Reactome.
DR   GO; GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc.
DR   CDD; cd00195; UBCc; 1.
DR   Gene3D; 3.10.110.10; -; 1.
DR   InterPro; IPR000608; UBQ-conjugat_E2.
DR   InterPro; IPR023313; UBQ-conjugating_AS.
DR   InterPro; IPR016135; UBQ-conjugating_enzyme/RWD.
DR   Pfam; PF00179; UQ_con; 1.
DR   SUPFAM; SSF54495; SSF54495; 1.
DR   PROSITE; PS00183; UBIQUITIN_CONJUGAT_1; 1.
DR   PROSITE; PS50127; UBIQUITIN_CONJUGAT_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Isopeptide bond; Nucleotide-binding; Nucleus;
KW   Polymorphism; Reference proteome; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:21406692}.
FT   CHAIN         2    193       Ubiquitin-conjugating enzyme E2 E1.
FT                                /FTId=PRO_0000082470.
FT   COMPBIAS      9     18       Poly-Ser.
FT   ACT_SITE    131    131       Glycyl thioester intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00388,
FT                                ECO:0000255|PROSITE-ProRule:PRU10133}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:21406692}.
FT   CROSSLNK    136    136       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ISG15).
FT   VAR_SEQ       1     50       MSDDDSRASTSSSSSSSSNQQTEKETNTPKKKESKVSMSKN
FT                                SKLLSTSAK -> MKEVGRPREVRGRPGKS (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_045884.
FT   VAR_SEQ      51     67       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_047200.
FT   VARIANT      25     25       E -> D (in dbSNP:rs36060625).
FT                                /FTId=VAR_061868.
FT   CONFLICT    131    131       C -> R (in Ref. 5; BI223271).
FT                                {ECO:0000305}.
FT   HELIX        22     24       {ECO:0000244|PDB:3BZH}.
FT   HELIX        42     61       {ECO:0000244|PDB:3BZH}.
FT   STRAND       67     74       {ECO:0000244|PDB:3BZH}.
FT   STRAND       78     84       {ECO:0000244|PDB:3BZH}.
FT   TURN         90     93       {ECO:0000244|PDB:3BZH}.
FT   STRAND       95    101       {ECO:0000244|PDB:3BZH}.
FT   TURN        104    108       {ECO:0000244|PDB:3BZH}.
FT   STRAND      112    117       {ECO:0000244|PDB:3BZH}.
FT   HELIX       133    135       {ECO:0000244|PDB:3BZH}.
FT   TURN        136    138       {ECO:0000244|PDB:3BZH}.
FT   HELIX       145    157       {ECO:0000244|PDB:3BZH}.
FT   HELIX       167    175       {ECO:0000244|PDB:3BZH}.
FT   HELIX       177    191       {ECO:0000244|PDB:3BZH}.
SQ   SEQUENCE   193 AA;  21404 MW;  2FBC50BE2A6A0008 CRC64;
     MSDDDSRAST SSSSSSSSNQ QTEKETNTPK KKESKVSMSK NSKLLSTSAK RIQKELADIT
     LDPPPNCSAG PKGDNIYEWR STILGPPGSV YEGGVFFLDI TFTPEYPFKP PKVTFRTRIY
     HCNINSQGVI CLDILKDNWS PALTISKVLL SICSLLTDCN PADPLVGSIA TQYMTNRAEH
     DRMARQWTKR YAT
//
